Dipna Pharmachem Q4 results, quarter to Mar 2026
BSE: 543594Pharmaceuticals & BiotechnologySmall Cap
DIPNA PHARMACHEM LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2022
Last close ₹3.93up ₹0.20 (5.36%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹3.73.
30 Oct: open ₹3.86, high ₹3.93, low ₹3.82
52-week range of traded prices to 30 Oct 2026
₹3.62Low, 29 Oct 2026₹20.50High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹10 Cr3,953rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 24,000
Dipna Pharmachem filed its Q4 results for the quarter to Mar 2026 on 2 Jul 2026 at 9:28 pm, standalone: the listed company alone, without its subsidiaries.
Q4 results, quarter to Mar 2026
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹2.02 Cr
- Operating profitOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary
- ₹0.43 Cr
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- ₹0.18 Cr
- Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary
- ₹0.07
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- 21.4%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 8.8%
From revenue to net profit, ₹ crore
- Revenue2.0
- Materials and goods+1.9
- Employee costs−0.1
- Other expenses−3.4
- Operating profit0.4
- Depreciation0.0
- Other income0.0
- Finance costs−0.2
- Profit before tax0.2
- Tax0.0
- Net profit0.2
Dipna Pharmachem results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Mar 2026. Results for the quarter to Jun 2026 were due by 14 Aug 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date
| ₹ crore | Mar 2026Q4 |
|---|---|
| Revenue from operations | 2.02 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | 1.59 |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | −1.89 |
| Employee costsEmployee costs. Salaries, wages, bonuses and other benefits paid to staff in the period. Employee costs in the glossary | 0.10 |
| Other expensesOther expenses. Every operating cost besides materials and staff: power, rent, freight, repairs, marketing and the like. Other expenses in the glossary | 3.37 |
| Operating profit before depreciation | 0.43 |
| Operating margin | 21.4% |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 0.00 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | 0.03 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | 0.23 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | 0.00 |
| Profit before tax | 0.22 |
| 0.04 | |
| Tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossary | 19.8% |
| Net profit | 0.18 |
| Net margin | 8.8% |
| Earnings per share | ₹0.07 |
Earnings per share in rupees, restated for later splits and bonuses.
Segment results by quarter
Standalone, ₹ crore, quarters to Mar 2026.Dipna Pharmachem segment results by year
Steel Segment
Revenue, ₹ croreProfit, ₹ croreChemicals Segment
Revenue, ₹ croreProfit, ₹ crore
| ₹ crore | Mar 2026 |
|---|---|
| Revenue of all businesses | 2.0 |
| Company revenue, as in its resultsCompany revenue. The company's revenue from operations for the period in its results, on the same accounts as its segments. It is below the businesses' sum where they sell to one another, or where the segments include a business the results report as discontinued. | 2.0 |
| 0.0 | |
| ProfitSegment profit. What the business earned before tax and finance costs, as the company measures each of its businesses. Segment profit in the glossary | 0.8 |
| AssetsSegment assets. What the company holds for this business at the period end: plant, stock, receivables and the like. Segment assets in the glossary | 7.2 |
| LiabilitiesSegment liabilities. What this business owes at the period end, such as payments due to suppliers. Segment liabilities in the glossary | 21.0 |
| Capital employedCapital employed in the segment. Segment assets less segment liabilities at the period end: the money tied up in this business. Capital employed in the segment in the glossary | −13.8 |
| Revenue | 2.0 |
Profit is before tax and finance costs, the way companies report their segments.
Dipna Pharmachem results by half year
Standalone: the listed company alone, without its subsidiaries. The half years to Sep 2025 in the same span that the quarters on record do not fully cover.
| ₹ crore | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025Filed 7 Jul | Sep 2025Filed 26 Nov |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 48.6 | 51.3 | 74.0 | 90.3 | 90.6 | 34.3 | 72.3 |
| 47.7 | – | 72.5 | – | 89.1 | – | 70.6 | |
| Materials and goods bought | 46.5 | 49.0 | 71.4 | 86.5 | 87.5 | 26.3 | 62.3 |
| Employee costs | 0.2 | – | 0.2 | – | 0.2 | – | 0.2 |
| Other expenses | 1.0 | – | 0.9 | – | 1.5 | – | 8.1 |
| Operating profit before depreciation | 0.9 | – | 1.5 | – | 1.5 | – | 1.7 |
| Operating margin | 1.9% | – | 2.1% | – | 1.6% | – | 2.3% |
| Depreciation and amortisation | 0.0 | – | 0.0 | – | 0.0 | – | 0.0 |
| Other income | 0.0 | 0.0 | 0.1 | −0.1 | 0.0 | 0.0 | 1.2 |
| Finance costs | 0.4 | 0.5 | 0.9 | 1.1 | 1.0 | 1.0 | 1.0 |
| Profit before tax | 0.5 | 0.9 | 0.8 | 0.6 | 0.5 | 1.0 | 1.9 |
| 0.1 | 0.3 | 0.2 | 0.1 | 0.1 | 0.3 | 0.5 | |
| Tax rate | 26.5% | 37.6% | 26.0% | 20.4% | 26.0% | 34.0% | 26.0% |
| Net profit | 0.3 | 0.6 | 0.6 | 0.5 | 0.3 | 0.6 | 1.4 |
| Net margin | 0.7% | 1.1% | 0.8% | 0.5% | 0.4% | 1.9% | 2.0% |
| Earnings per share | ₹0.28 | ₹0.48 | ₹0.49 | ₹0.41 | ₹0.14 | ₹0.27 | ₹0.59 |
Earnings per share in rupees, restated for later splits and bonuses.